Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PAMIDRONATE vs PANITUMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PAMIDRONATE vs PANITUMUMAB: Safety Overview

Metric PAMIDRONATE PANITUMUMAB
Total FAERS Reports 1,639 10,876
Deaths Reported 184 1,666
Death Rate 11.2% 15.3%
Hospitalizations 484 3,121
Average Patient Age 55.1 yrs 63.0 yrs
% Female Patients 61.6% 36.9%
FDA Approval Date Apr 30, 2001 N/A
Manufacturer Hospira, Inc. Amgen Inc
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Prescription